174 related articles for article (PubMed ID: 11882906)
1. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
4. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
Johannessen AL; Torp SH
Pathol Oncol Res; 2006; 12(3):143-7. PubMed ID: 16998593
[TBL] [Abstract][Full Text] [Related]
6. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
7. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
8. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
11. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
12. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.
Ho DM; Wong TT; Hsu CY; Ting LT; Chiang H
Cancer; 1998 Jun; 82(12):2459-66. PubMed ID: 9635540
[TBL] [Abstract][Full Text] [Related]
14. Proliferative index in astrocytic tumours.
Rathi KR; Radotra BD; Khosla VK
Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
17. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
19. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
20. Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.
Sarkar C; Ralte AM; Sharma MC; Mehta VS
Br J Neurosurg; 2002 Aug; 16(4):335-42. PubMed ID: 12389885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
